Skip to main content
Maher Albitar, MD, Pathology, Irvine, CA

MaherAlbitarMD

Pathology Irvine, CA

Anatomic Pathology, Clinical Pathology

Physician

Dr. Albitar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Albitar's full profile

Already have an account?

  • Office

    175 Technology Dr.
    Irvine, CA 92618
    Phone+1 657-202-5950
    Fax+1 949-301-9719

Education & Training

  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 1979

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2023 - 2026
  • RI State Medical License
    RI State Medical License 1984 - 2026
  • VA State Medical License
    VA State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 2003 - 2025
  • CT State Medical License
    CT State Medical License 2023 - 2025
  • FL State Medical License
    FL State Medical License 2017 - 2025
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Genomic Testing Cooperative and Its Co-Op Members First to Use Artificial Intelligence to Distinguish Between 45 Hematologic and Solid Neoplasms Using Targeted Transcriptome
    Genomic Testing Cooperative and Its Co-Op Members First to Use Artificial Intelligence to Distinguish Between 45 Hematologic and Solid Neoplasms Using Targeted TranscriptomeOctober 13th, 2022
  • CorePath Laboratories Internalizes Genomic Testing Cooperative's State-of-the-Art Next-Generation Sequencing (NGS) Testing for Solid Tumors and Hematologic Neoplasms
    CorePath Laboratories Internalizes Genomic Testing Cooperative's State-of-the-Art Next-Generation Sequencing (NGS) Testing for Solid Tumors and Hematologic NeoplasmsMay 16th, 2024